To learn more about our editorial approach, explore The Direct Message methodology. Eight-year-old Freddie Truelove used to have hundreds of seizures a day. Now he has a couple a week — and his mother ...
For decades, the treatment of developmental and epileptic encephalopathies has focused on suppressing seizures rather than modifying the underlying biology of disease. In the New England Journal of ...
Please provide your email address to receive an email when new articles are posted on . LOS ANGELES — Zorevunersen led to 75% to 80% seizure reduction in patients with Dravet syndrome, according to ...
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will present encore open-label extension data from the company’s investigation of EPX-100 (clemizole hydrochloride) in the ...
A novel first-in-class gene-regulation therapy for Dravet syndrome was associated with large reductions in seizures and improved functional outcomes in children with Dravet syndrome. Results from ...
UCB wants you to hear the sound of profound seizure reduction. Across a series of videos, the Belgian drugmaker makes the case that its Dravet syndrome drug Fintepla amplifies family life by allowing ...
Most parents worry about scraped knees, tumbles on the playground or gym class injuries. But for the Raia and Tisdale families, their everyday fears are life-threatening: a seizure that can strike ...
Takeda Drug Fails Pivotal Tests in 2 Rare Epilepsies; Path Forward Depends on Regulatory Flexibility
A Takeda Pharmaceutical drug in development for rare forms of epilepsy that are resistant to anti-seizure medications has failed to meet the main goals of two placebo-controlled pivotal studies, a ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Participants given STK-001 in one dose experienced a 43% ...
Zorevenersen, an experimental drug for severe form of epilepsy, Dravet syndrome, reduced seizures by up to 91% in children aged between two and 18 years old. The corresponding study was published in ...
Groundbreaking Phase 1/2a clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children’s Hospital of Chicago, show that the first gene regulation treatment for epilepsy is safe and ...
A new experimental treatment for children with a hard-to-treat form of epilepsy is safe and can reduce seizures dramatically, helping them lead much healthier and happier lives, the findings of a UCL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results